What Changes are in Store for the Cancer Drug Fund?

The National Institute for Health and Care Excellence (NICE) and the National Health Service (NHS) England have proposed changes to the operation of the Cancer Drugs Funds. Why does the fund need reform and what will that reform look like? See more here. (Source: Pharmafile, 1/14/16)

You might also be interested in:

PAI and BresMed Join Forces to Support Expanded Use of More… July 22, 2019
Biomarkers and Companion diagnostics: Payer Insights September 26, 2019
Pharmerit Expands Market Access Support in Asia January 17, 2019
Applied Health Economics for Public Health Practice and Research March 28, 2019
The Growing Influence of the Institute of Clinical and… November 21, 2019
Leveraging Technology to Reduce Costs in Clinical Trials June 30, 2019
The Global Use of Medicine in 2019 and Outlook to 2023 January 29, 2019